A Reduction in ADAM17 Expression Is Involved in the Protective Effect of the PPAR-α Activator Fenofibrate on Pressure Overload-Induced Cardiac Hypertrophy

por Zeng, Si-Yu, Lu, Hui-Qin, Yan, Qiu-Jiang, Zou, Jian
Publicado 2018

Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Ac...

por Zeng, Si-yu, Yan, Qiu-jiang, Yang, Li, Mei, Qing-hua, Lu, Hui-qin
Publicado 2020

Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4‐ROS‐ADAM17 pathway

por Zeng, Si‐yu, Yang, Li, Lu, Hui‐qin, Yan, Qiu‐jiang, Gao, Ling, Qin, Xu‐ping
Publicado 2018

Evidence That ADAM17 Mediates the Protective Action of CGRP against Angiotensin II-Induced Inflammation in Vascular Smooth Muscle Cells

por Zeng, Si-yu, Yang, Li, Hong, Chen-liang, Lu, Hui-qin, Yan, Qiu-jiang, Chen, Yan, Qin, Xu-ping
Publicado 2018